Moderna CEO says data for Omicron-specific shot likely available in March

Summary by Ground News

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks. The company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. Many countries are already offering a third dose of a COVID-19 vaccine to their citizens.

4 months ago·Washington, United States

News Articles

Times of India

Moderna CEO says data for Omicron-specific shot likely available in March

"The vaccine is being finished, it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

4 months ago·Mumbai, India

Read Full Article

Reuters

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

4 months ago·United Kingdom

Read Full Article

CTV News

Moderna CEO says data for Omicron-specific shot likely available in March

4 months ago·Toronto, Canada

Read Full Article

Financial Post

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be…

4 months ago·Canada

Read Full Article

France24

Covid-flu joint booster jab possible late 2023: Moderna

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.

4 months ago·France

Read Full Article